Medicure (MCUJF) Non-Current Debt (2009 - 2026)

Medicure (MCUJF) posted quarterly Non-Current Debt of $62711.7 for Q1 2026, up 4.11% quarter-over-quarter from $60235.2 in Q4 2025.

Medicure (MCUJF) Non-Current Debt (2009 - 2026) Analysis & Trends

Medicure's Non-Current Debt history runs 13 years deep, the most recent figure standing at $62711.7 for Q1 2026.

In Q1 2026, Non-Current Debt changed N/A year-over-year to $62711.7; the TTM figure through Mar 2026 stood at $62711.7 (changed N/A YoY), while the FY2025 annual figure was $60120.6, changed N/A from the prior year.
Non-Current Debt for Q1 2026 stood at $62711.7, up from $60235.2 in the prior quarter.
The five-year high for Non-Current Debt was $62711.7 in Q1 2026, with the low at $59180.4 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Haleon	44.40 Bn	43.44 Bn	-	-8.44 Bn
2	Teva Pharmaceutical Industries	43.85 Bn	40.20 Bn	2.15 Bn	12.09 Bn
3	Zoetis	32.45 Bn	30.77 Bn	1.05 Bn	9.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.84 Bn	5.10 Bn	27.73 Bn
5	United Therapeutics	22.17 Bn	19.50 Bn	683.80 Mn	-
6	Viatris	18.94 Bn	18.06 Bn	1.46 Bn	11.61 Bn
7	Neurocrine Biosciences	15.52 Bn	15.13 Bn	935.80 Mn	-
8	Elanco Animal Health	11.95 Bn	11.42 Bn	798.00 Mn	3.85 Bn
9	Dr Reddys Laboratories	10.16 Bn	9.99 Bn	-	130.00 Mn
10	Medicure	96.01 Mn	94.89 Mn	2.57 Mn	-

Download Data